Former Monk Sues L'Oreal Over Anti-Aging Formula
Says he was selling it to raise money for the poor until cosmetics giant came along
By Newser Editors and Wire Services
Posted Aug 30, 2017 4:04 PM CDT
Shrink
In this Feb. 5, 2009 file photo, University of Massachusetts professor Dr. James Dobson, Jr., center, posses with his wife Susan, left, and Teresian Carmelite Prior Dennis-Anthony Wyrzykowski, right, in Dobson's laboratory at the University of Massachusetts Medical School in Worcester, Mass.   (Steven Senne)
camera-icon View 2 more images

(Newser) – A former Roman Catholic monk has filed a federal lawsuit against cosmetics giant L'Oreal, accusing the company of stealing patented technology in an anti-aging wrinkle cream that his charity was selling to raise money for the poor. Dennis Wyrzykowski and his company, Carmel Laboratories LLC, have been joined in the lawsuit by the University of Massachusetts Medical School, which developed the technology and licensed it to Carmel in 2009. According to the lawsuit, the cream, called Easeamine, is made using technology inspired by a discovery by two UMass scientists that adenosine, a chemical compound found in the heart, can promote skin elasticity. The lawsuit, filed in June and amended this month, alleges L'Oreal was aware UMass held the patent for the science.

It alleges L'Oreal had been denied patents because of their similarity to those granted to UMass, but the cosmetic company went ahead with a line of products based on the adenosine technology, the AP reports. Wyrzykowski, who leads a religious charity known as the Teresian Carmelites in Millbury, Massachusetts, said in an interview Tuesday that he was selling the cream online for $65 per tube to support the Carmelites work with prisoners, drug addicts, and school children. He said the availability of the L'Oreal products decimated the Carmelites business, forcing him to sell property that was going to be used for a spiritual center and curtailing other charitable works. L'Oreal's attorneys argue in court documents that L'Oreal believes its use of adenosine falls outside the University of Massachusetts patents.

My Take on This Story
Show results without voting  |  
5%
46%
13%
19%
2%
14%